Vaping-Seeking Clarity in a Time of Uncertainty.
As of October 28, 2019, 49 states have reported more than 1600 possible cases of severe pulmonary disease related to vaping—the inhalation of a heated, aerosolized solution—to the CDC.
Abstract
As of October 28, 2019, 49 states have reported more than 1600 possible cases of severe pulmonary disease related to vaping—the inhalation of a heated, aerosolized solution—to the Centers for Disease Control and Prevention (CDC).1 To date, 34 deaths have been attributed to e-cigarette, or vaping, product use–associated lung injury (EVALI). This has resulted in a recommendation from the CDC that the public avoid the use of e-cigarette products, a proposed federal prohibition on certain products and flavors, and much uncertainty on the part of patients and clinicians. In the midst of this uncertainty, it is important to try to provide some clarity.